---
figid: PMC8591171__fonc-11-748698-g001
figtitle: Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived
  Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy
  Targeting the Spliceosome
organisms:
- NA
pmcid: PMC8591171
filename: fonc-11-748698-g001.jpg
figlink: /pmc/articles/PMC8591171/figure/f1/
number: F1
caption: 'Metabolism of methylglyoxal by the glyoxalase pathway, major glycation reactions
  of methylglyoxal and clinical and investigational antitumor drugs. (A) Metabolism
  of methylglyoxal by the glyoxalase pathway. (B) Glycation of arginine residues by
  methylglyoxal from hydroimidazolone, MG-H1. (C) Glycation of guanyl moieties of
  DNA by methylglyoxal from isomeric imidazopurinones, MGdG. (D–G) Molecular structures
  of antitumor drugs. (D) Alkylating agents: mechlorethamine, mitomycin C, and cisplatin.
  (E) Topoisomerase inhibitors: camptothecin, doxorubicin, and etoposide. (F) Antitubulins:
  paclitaxel and vincristine. (G) Antimetabolites: methotrexate and glyoxalase 1 inhibitor
  prodrug, S-p-bromobenzylglutathione cyclopentyl diester (BBGD).'
papertitle: Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived
  Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy
  Targeting the Spliceosome.
reftext: Muhanad Alhujaily, et al. Front Oncol. 2021;11:748698.
year: '2021'
doi: 10.3389/fonc.2021.748698
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: methylglyoxal | glyoxalase | cancer chemotherapy | multidrug resistance
  | proteomics
automl_pathway: 0.836027
figid_alias: PMC8591171__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8591171__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8591171__fonc-11-748698-g001.html
  '@type': Dataset
  description: 'Metabolism of methylglyoxal by the glyoxalase pathway, major glycation
    reactions of methylglyoxal and clinical and investigational antitumor drugs. (A)
    Metabolism of methylglyoxal by the glyoxalase pathway. (B) Glycation of arginine
    residues by methylglyoxal from hydroimidazolone, MG-H1. (C) Glycation of guanyl
    moieties of DNA by methylglyoxal from isomeric imidazopurinones, MGdG. (D–G) Molecular
    structures of antitumor drugs. (D) Alkylating agents: mechlorethamine, mitomycin
    C, and cisplatin. (E) Topoisomerase inhibitors: camptothecin, doxorubicin, and
    etoposide. (F) Antitubulins: paclitaxel and vincristine. (G) Antimetabolites:
    methotrexate and glyoxalase 1 inhibitor prodrug, S-p-bromobenzylglutathione cyclopentyl
    diester (BBGD).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 'On'
  - Hn
  - CSN1b
  - how
  - Dg
  - AP-1gamma
  - ci
  - ck
  - pt
---
